Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2026-01-07 @ 5:00 AM
Study NCT ID:
NCT06541860
Status:
RECRUITING
Last Update Posted:
2024-08-07
First Post:
2024-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DAratumumab and REvlimid REfractory MM
Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia